Avivia Projects

Avivia is a Netherlands-based pharmaceutical development company specializing in the creation of value-added medicines through drug repurposing and advanced formulation techniques. The company operates a hybrid business model, offering contract research and development services (CRO) while simultaneously advancing an internal pipeline of proprietary products. Avivia focuses on the 505(b)(2) regulatory pathway in the US and the hybrid application route in Europe to minimize development risk and time-to-market. Their core expertise lies in CMC, regulatory affairs, and clinical strategy for complex small molecule therapeutics. The company is headquartered at the Novio Tech Campus in Nijmegen, leveraging a strong network of regional and international partners.